MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Intestinal Methanogen Overgrowth (IMO) More Prevalent than SIBO in Parkinson’s disease with Constipation: Preliminary Results

    A. Sharma, Y. Yan, T. Karunaratne, A. Eubanks, J. Kurek, J. Morgan, S. Rao (Augusta, GA, USA)

    Objective: Our aim is to quantify the prevalence of small intestinal bacterial overgrowth (SIBO) and intestinal methanogen overgrowth (IMO) in PD subjects with constipation compared…
  • MDS Virtual Congress 2020

    Urinary Symptoms and Parkinson’s Disease: The Patient’s Perspective

    J. Wertheimer, B. Reynolds, C. Walton, J. McNamara, T. Hamran, S. Freedland (Los Angeles, CA, USA)

    Objective: To learn about prevalence rates and the impact of urinary symptoms on day-to-day function and quality of life from the patient’s perspective. Background: Urinary…
  • MDS Virtual Congress 2020

    Movement Disorders After Bariatric Surgeries – Case Series

    G. Fabiani, C.H Camargo, H. Teive (Curitiba, Brazil)

    Objective: Our objective is to report 6 cases series of MD after Bariatric surgeries (BS) and one case after hiatal surgery, with BS behavior. Background:…
  • MDS Virtual Congress 2020

    Effectiveness of lead position with microelectrode recording based support vector machine for characterizing the sub-cortical-structures via deep brain stimulus in Parkinson`s disease

    V. Rama Raju (Hyderabad, India)

    Objective: To develop artificial intelligence(AI) machine/deep learning techniques for processing/analyzing MER signals of STN which will help the surgical-team (neurologists,neurosurgeons) for deciding optimal location of…
  • MDS Virtual Congress 2020

    Prevalence, Impact, and Suboptimal Treatment of Depression in the Fox Insight Cohort

    R. Dobkin, M. Gara, S. Mann, K. Rodriguez, A. Interian (Piscataway, NJ, USA)

    Objective: Addressing unmet mental health needs in Parkinson’s disease (PD) requires delineating their scope and impact. This study evaluated (1) depressive symptom prevalence and treatment…
  • MDS Virtual Congress 2020

    Increased illusory responses in non-hallucinating, cognitively impaired Lewy body disease patients

    M. Shahid, A. Rawls, V. Ramirez, S. Ryman, V. Santini, L. Yang, S. Sha, J. Hall, T. Montine, L. Tian, B. Cholerton, V. Henderson, M. Yutsis, K. Poston (Stanford, CA, USA)

    Objective: To determine whether non-hallucinating Lewy body disease-spectrum patients report increased illusory responses. Background: Pareidolias are specific illusions of faces and objects perceived in formless…
  • MDS Virtual Congress 2020

    Using mindfulness to improve self-awareness in Parkinson’s disease patients – preliminary results of a randomized controlled trial

    T. Buchwitz, F. Maier, A. Greuel, C. Eggers (Marburg, Germany)

    Objective: This clinical trial aims to investigate the effects and feasibility of a newly developed 8-week mindfulness intervention on self-awareness in Parkinson’s disease (PD) patients.…
  • MDS Virtual Congress 2020

    Blood-Brain Barrier Opening with Focused Ultrasound in Parkinson´s Disease with Cognitive Impairment: A Safety and Feasibility Study

    C. Gasca-Salas, J. Pineda-Pardo, B. Fernández-Rodríguez, R. Rodríguez-Rojas, F. Hernández, I. Obeso, M. del Álamo, P. Guida, D. Mata-Marin, R. Martínez-Fernández, C. Ordás-Bandera, G. Foffani, I. Rachmilevitch, J. Obeso (Móstoles, Spain)

    Objective: To evaluate the safety and feasibility of MR guided focused ultrasound (MRgFUS) blood-brain barrier (BBB) opening in the cortex or the striatum in Parkinson´s…
  • MDS Virtual Congress 2020

    Enhancement of executive functions but not memory by multidomain cognitive group training in Parkinson patients with mild cognitive impairment: A multicenter randomized controlled trial

    E. Kalbe, A.K Folkerts, A. Ophey, C. Eggers, S. Elben, K. Dimenshteyn, P. Sulzer, C. Schulte, N. Schmidt, C. Schlenstedt, D. Berg, K. Witt, L. Wojtecki, I. Liepelt-Scarfone (Cologne, Germany)

    Objective: To determine cognitive training (CT) effects in Parkinson’s disease (PD) patients with mild cognitive impairment (PD-MCI) on cognitive and non-cognitive outcomes compared to an…
  • MDS Virtual Congress 2020

    Baseline results of a virtual longitudinal, observational study of Parkinson’s disease: The AT-HOME PD cohort

    T. Myers, R. Schneider, L. Omberg, E. Macklin, E. Baloga, P. Snyder, S. Duquette, K. Amodeo, C. Tarolli, J. Adams, C. Lungu, J. Gottesman, E. Kayson, E. Dorsey, L. Mangravite, T. Simuni, M. Schwarzschild (Boston, MA, USA)

    Objective: To describe the baseline characteristics of Parkinson’s disease (PD) clinical trial participants enrolled in a remote, long-term observational follow-up study. Background: Participation in clinical…
  • « Previous Page
  • 1
  • …
  • 34
  • 35
  • 36
  • 37
  • 38
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley